Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral misoprostol versus vaginal dinoprostone for induction of labor
ACTRN12613000479707Phase 3Withdrawn
- Sponsor
- King Fahd Armed Forces Hospital
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of misoprostol, Propess and dinoprostone in induced labor (2 arms), sponsored by King Fahd Armed Forces Hospital. Primary endpoint: Proportion achieving vaginal delivery within 24 hours. Planned start Nov 2012; status: withdrawn.
02
Drugs
misoprostolPropessdinoprostone
03
Conditions
induced labor
Beyond the preview
Go deeper on ACTRN12613000479707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000479707.